Skip to content Skip to footer
Pegfilgrastim-Apgf: Benefits, Reviews, Info, Side Effects!
Rx Details
Pegfilgrastim-Apgf
Neulasta, Fulphila, Udenyca
Pegfilgrastim-Apgf
Prescription
Biosimilar
Drugs
Prescription Only
stimulates white blood cell production, reduces risk of infection in chemotherapy patients, supports recovery of bone marrow, decreases incidence of febrile neutropenia, aids in faster recovery from neutropenia
Bone Pain, Dizziness, Fatigue, Fever, Headache, Injection Site Reactions, Joint Pain, Muscle Pain, Nausea, Pain In Arms Or Legs, Rash
Pegfilgrastim-apgf is a biosimilar to pegfilgrastim, which is used to reduce the risk of infection in patients undergoing chemotherapy by stimulating the production of white blood cells. The typical dosage for pegfilgrastim and its biosimilars, including pegfilgrastim-apgf, is usually a single subcutaneous injection of 6 mg per chemotherapy cycle. However, the exact dosage and administration schedule can vary based on the specific treatment regimen and patient needs, so it is important to follow the prescribing physician’s instructions. Always consult with a healthcare provider for personalized medical advice.
Neutropenia, chemotherapy-induced neutropenia
Generally well-tolerated with mild side effects.
No Interactions Reported
$300 – $500
$3,900

A Synopsis of

Pegfilgrastim-Apgf

Pegfilgrastim-Apgf is a medication that is commonly used in the treatment of patients undergoing chemotherapy. It belongs to a class of drugs known as colony-stimulating factors, which work by stimulating the production of white blood cells in the body. This is important because chemotherapy can often suppress the immune system, leaving patients vulnerable to infections.

One of the key benefits of Pegfilgrastim-Apgf is its long-acting nature, as it only needs to be administered once per chemotherapy cycle. This can help simplify treatment regimens for patients and reduce the burden of frequent injections.

It is important to note that Pegfilgrastim-Apgf is not without potential side effects. Common side effects may include bone pain, muscle aches, and fatigue. However, these side effects are usually mild and temporary.

As with any medication, it is important to discuss the potential risks and benefits of Pegfilgrastim-Apgf with your healthcare provider. They can help determine if this medication is the right choice for you based on your individual medical history and treatment plan.

Overall, Pegfilgrastim-Apgf is a valuable tool in the management of chemotherapy-induced neutropenia. By boosting white blood cell production, it can help reduce the risk of infections and improve overall outcomes for patients undergoing cancer treatment. If you have any questions or concerns about Pegfilgrastim-Apgf, do not hesitate to reach out to your healthcare provider for more information.

RxDb Legal Disclaimer

The information provided on RxDB.net is for informational purposes only and is not intended to replace professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare professional, such as a doctor or pharmacist, for any questions or concerns regarding your health, medications, or medical conditions. Reliance on any information provided on this website is solely at your own risk. RxDB.net does not provide medical or pharmaceutical services and is not liable for any decisions made based on the information contained herein.

PAGE LAST UPDATED

Health Education Through Aggregation

Sign up for the Rx Database Newsletter!
Menu
Questions?

Website By Foxco © 2025. All rights reserved.

0
Would love your thoughts, please comment.x
()
x
en_USEN